Mercator Financial Statements From 2010 to 2024

MRC Stock   52.50  1.80  3.55%   
Mercator Medical financial statements provide useful quarterly and yearly information to potential Mercator Medical SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mercator Medical financial statements helps investors assess Mercator Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mercator Medical's valuation are summarized below:
Mercator Medical SA does not presently have any fundamental ratios for analysis.
Check Mercator Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mercator Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mercator financial statements analysis is a perfect complement when working with Mercator Medical Valuation or Volatility modules.
  
This module can also supplement various Mercator Medical Technical models . Check out the analysis of Mercator Medical Correlation against competitors.

Mercator Medical SA Company Return On Asset Analysis

Mercator Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Mercator Medical Return On Asset

    
  -0.0044  
Most of Mercator Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mercator Medical SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Mercator Medical SA has a Return On Asset of -0.0044. This is 99.95% lower than that of the Healthcare sector and 99.98% lower than that of the Medical Instruments & Supplies industry. The return on asset for all Poland stocks is 96.86% lower than that of the firm.

Mercator Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mercator Medical's current stock value. Our valuation model uses many indicators to compare Mercator Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mercator Medical competition to find correlations between indicators driving Mercator Medical's intrinsic value. More Info.
Mercator Medical SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mercator Medical's earnings, one of the primary drivers of an investment's value.

About Mercator Medical Financial Statements

Mercator Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Mercator Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Mercator Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Mercator Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Pair Trading with Mercator Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mercator Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mercator Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Mercator Stock

  0.7CEZ CEZ asPairCorr
The ability to find closely correlated positions to Mercator Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mercator Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mercator Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mercator Medical SA to buy it.
The correlation of Mercator Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mercator Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mercator Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mercator Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Mercator Stock Analysis

When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.